Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ayana Uchimura"'
Autor:
Chiho Furuya, Hajime Yasuda, Makoto Hiki, Shuichi Shirane, Tomohito Yamana, Ayana Uchimura, Tadaaki Inano, Tomoiku Takaku, Yasuharu Hamano, Miki Ando
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Persistent COVID-19 is a well recognized issue of concern in patients with hematological malignancies. Such patients are not only at risk of mortality due to the infection itself, but are also at risk of suboptimal malignancy-related outcomes because
Externí odkaz:
https://doaj.org/article/35e8342eba5e41138270db7584b65e50
Autor:
Ayana Uchimura, Hajime Yasuda, Hiroko Onagi, Tadaaki Inano, Shuichi Shirane, Midori Ishii, Yoko Azusawa, Yasuharu Hamano, Hidetaka Eguchi, Masami Arai, Jun Ando, Miki Ando
Publikováno v:
Heliyon, Vol 10, Iss 2, Pp e24801- (2024)
Background: Acute graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT) with significant morbidity and mortality, and efficacy of currently available therapeutics are limited. Acute
Externí odkaz:
https://doaj.org/article/2568fad0772844d3aee047e5688cdf1f
Autor:
Ayana Uchimura, Hajime Yasuda, Jun Ando, Yasunori Ota, Makoto Sasaki, Tomoiku Takaku, Yutaka Tsukune, Miyuki Tsutsui, Yoko Edahiro, Naoki Watanabe, Tomonori Ochiai, Norio Komatsu, Miki Ando
Publikováno v:
Case Reports in Oncology, Vol 15, Iss 1, Pp 263-266 (2022)
Chemotherapy for hemodialysis (HD) patients is a challenging situation because HD patients are generally frail, and the pharmacokinetics and pharmacodynamics of most chemotherapeutics in HD patients are unknown. We report a classical Hodgkin lymphoma
Externí odkaz:
https://doaj.org/article/2360cfab3b874c888bf45da5c3e23ed0
Autor:
Naoki Watanabe, Kazuya Sugimoto, Yosuke Miyashita, Hajime Yasuda, Ayana Uchimura, Misa Tateyama, Yusuke Ochi, Norio Komatsu, Yutaka Tsukune
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia
Clinical Lymphoma, Myeloma & Leukemia
Clinical Lymphoma, Myeloma & Leukemia
The global COVID-19 pandemic has been reported to inflict higher death rates in patients with hematologic malignancies compared with the general population.1 Proposed theoretical mechanisms include lymphopenia, which is often seen in this patient gro